SCHEMBL9762260

SCHEMBL9762260

CCNc1nc(N2CCOCC2)sc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 4/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PIK3CD O00329 5/20 0.39
PIK3CA P42336 5/20 0.39
PIK3CB P42338 5/20 0.39
AR P10275 1/20 0.38
PIK3CG P48736 4/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 1/20 0.37
HPGD P15428 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALOX5 P09917 1/20 0.36
PTGS2 P35354 1/20 0.36
MAPK1 P28482 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046802 0.76 PIK3CD (0.40) ALDH1A1KDM4EMAPTGAASMN1; SMN2
SCHEMBL9762505 0.72 KMT2A (0.44) ALDH1A1KDM4EMAPTSMN1; SMN2CYP1A2
SCHEMBL9762334 0.72 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTSMN1; SMN2CYP1A2
SCHEMBL9762538 0.71 SMN1; SMN2 (0.38) ALDH1A1KDM4EMAPTGAASMN1; SMN2
SCHEMBL9762582 0.70 PGK1 (0.40) ALDH1A1MAPTGAASMN1; SMN2CYP1A2
SCHEMBL3399391 0.70 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTSMN1; SMN2CYP1A2
SCHEMBL31178240 0.68 MAPT (0.42) ALDH1A1KDM4EMAPTSMN1; SMN2HPGD
SCHEMBL9762197 0.68 PGK1 (0.38) ALDH1A1MAPTSMN1; SMN2
SCHEMBL9761837 0.67 CYP1A2 (0.43) ALDH1A1MAPTGAASMN1; SMN2CYP1A2
SCHEMBL9761231 0.67 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed